Summary
Global Endocrinology Drugs Market 2023-2027
The analyst has been monitoring the endocrinology drugs market and is poised to grow by $36551.24 mn from 2023-2027, accelerating at a CAGR of 7.82% during the forecast period. Our report on the endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the incidence of endocrine disorders, a promising pipeline for endocrinology, and research in novel dosage formulations and drug delivery systems.
The endocrinology drugs market is segmented as below:
By Therapy Area
• Diabetes drugs
• HGH
• Thyroid hormone disorders
• Others
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the association between obesity and endocrine disorders as one of the prime reasons driving the endocrinology drugs market growth during the next few years. Also, the use of biosimilars for endocrine disorders and the growing geriatric population will lead to sizable demand in the market.
The analyst presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the endocrinology drugs market covers the following areas:
• Endocrinology drugs market sizing
• Endocrinology drugs market forecast
• Endocrinology drugs market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading endocrinology drugs market vendors that include Abbott Laboratories, Acerus Pharmaceuticals Corp., Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Oramed Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and VeroScience LLC. Also, the endocrinology drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global endocrinology drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global endocrinology drugs market 2017 - 2021 ($ million)
4.2 Therapy Area Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapy Area Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Therapy Area
6.1 Market segments
Exhibit 30: Chart on Therapy Area - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy Area - Market share 2022-2027 (%)
6.2 Comparison by Therapy Area
Exhibit 32: Chart on Comparison by Therapy Area
Exhibit 33: Data Table on Comparison by Therapy Area
6.3 Diabetes drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Diabetes drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Diabetes drugs - Year-over-year growth 2022-2027 (%)
6.4 hGH - Market size and forecast 2022-2027
Exhibit 38: Chart on hGH - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on hGH - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on hGH - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on hGH - Year-over-year growth 2022-2027 (%)
6.5 Thyroid hormone disorders - Market size and forecast 2022-2027
Exhibit 42: Chart on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Therapy Area
Exhibit 50: Market opportunity by Therapy Area ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 51: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 52: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 53: Chart on Comparison by Distribution Channel
Exhibit 54: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 55: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 63: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 67: Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 Acerus Pharmaceuticals Corp.
Exhibit 116: Acerus Pharmaceuticals Corp. - Overview
Exhibit 117: Acerus Pharmaceuticals Corp. - Product / Service
Exhibit 118: Acerus Pharmaceuticals Corp. - Key offerings
12.4 Bayer AG
Exhibit 119: Bayer AG - Overview
Exhibit 120: Bayer AG - Business segments
Exhibit 121: Bayer AG - Key offerings
Exhibit 122: Bayer AG - Segment focus
12.5 Beta Cell NV
Exhibit 123: Beta Cell NV - Overview
Exhibit 124: Beta Cell NV - Product / Service
Exhibit 125: Beta Cell NV - Key offerings
12.6 Eli Lilly and Co.
Exhibit 126: Eli Lilly and Co. - Overview
Exhibit 127: Eli Lilly and Co. - Product / Service
Exhibit 128: Eli Lilly and Co. - Key offerings
12.7 Endo International Plc
Exhibit 129: Endo International Plc - Overview
Exhibit 130: Endo International Plc - Business segments
Exhibit 131: Endo International Plc - Key news
Exhibit 132: Endo International Plc - Key offerings
Exhibit 133: Endo International Plc - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 139: GlaxoSmithKline Plc - Overview
Exhibit 140: GlaxoSmithKline Plc - Business segments
Exhibit 141: GlaxoSmithKline Plc - Key offerings
Exhibit 142: GlaxoSmithKline Plc - Segment focus
12.10 Hanmi Pharm Co. Ltd.
Exhibit 143: Hanmi Pharm Co. Ltd. - Overview
Exhibit 144: Hanmi Pharm Co. Ltd. - Product / Service
Exhibit 145: Hanmi Pharm Co. Ltd. - Key offerings
12.11 Ipsen Pharma
Exhibit 146: Ipsen Pharma - Overview
Exhibit 147: Ipsen Pharma - Business segments
Exhibit 148: Ipsen Pharma - Key offerings
Exhibit 149: Ipsen Pharma - Segment focus
12.12 Merck and Co. Inc.
Exhibit 150: Merck and Co. Inc. - Overview
Exhibit 151: Merck and Co. Inc. - Business segments
Exhibit 152: Merck and Co. Inc. - Key news
Exhibit 153: Merck and Co. Inc. - Key offerings
Exhibit 154: Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Exhibit 155: Novartis AG - Overview
Exhibit 156: Novartis AG - Business segments
Exhibit 157: Novartis AG - Key offerings
Exhibit 158: Novartis AG - Segment focus
12.14 Novo Nordisk AS
Exhibit 159: Novo Nordisk AS - Overview
Exhibit 160: Novo Nordisk AS - Business segments
Exhibit 161: Novo Nordisk AS - Key offerings
Exhibit 162: Novo Nordisk AS - Segment focus
12.15 Pfizer Inc.
Exhibit 163: Pfizer Inc. - Overview
Exhibit 164: Pfizer Inc. - Product / Service
Exhibit 165: Pfizer Inc. - Key news
Exhibit 166: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 167: Sanofi SA - Overview
Exhibit 168: Sanofi SA - Business segments
Exhibit 169: Sanofi SA - Key news
Exhibit 170: Sanofi SA - Key offerings
Exhibit 171: Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 176: Inclusions checklist
Exhibit 177: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 178: Currency conversion rates for US$
13.4 Research methodology
Exhibit 179: Research methodology
Exhibit 180: Validation techniques employed for market sizing
Exhibit 181: Information sources
13.5 List of abbreviations
Exhibit 182: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global endocrinology drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Therapy Area Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy Area - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy Area - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy Area
Exhibits33: Data Table on Comparison by Therapy Area
Exhibits34: Chart on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Diabetes drugs - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Diabetes drugs - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Diabetes drugs - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on hGH - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on hGH - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on hGH - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on hGH - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Thyroid hormone disorders - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Thyroid hormone disorders - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Therapy Area ($ million)
Exhibits51: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits52: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by Distribution Channel
Exhibits54: Data Table on Comparison by Distribution Channel
Exhibits55: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Distribution Channel ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: Acerus Pharmaceuticals Corp. - Overview
Exhibits117: Acerus Pharmaceuticals Corp. - Product / Service
Exhibits118: Acerus Pharmaceuticals Corp. - Key offerings
Exhibits119: Bayer AG - Overview
Exhibits120: Bayer AG - Business segments
Exhibits121: Bayer AG - Key offerings
Exhibits122: Bayer AG - Segment focus
Exhibits123: Beta Cell NV - Overview
Exhibits124: Beta Cell NV - Product / Service
Exhibits125: Beta Cell NV - Key offerings
Exhibits126: Eli Lilly and Co. - Overview
Exhibits127: Eli Lilly and Co. - Product / Service
Exhibits128: Eli Lilly and Co. - Key offerings
Exhibits129: Endo International Plc - Overview
Exhibits130: Endo International Plc - Business segments
Exhibits131: Endo International Plc - Key news
Exhibits132: Endo International Plc - Key offerings
Exhibits133: Endo International Plc - Segment focus
Exhibits134: F. Hoffmann La Roche Ltd. - Overview
Exhibits135: F. Hoffmann La Roche Ltd. - Business segments
Exhibits136: F. Hoffmann La Roche Ltd. - Key news
Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits139: GlaxoSmithKline Plc - Overview
Exhibits140: GlaxoSmithKline Plc - Business segments
Exhibits141: GlaxoSmithKline Plc - Key offerings
Exhibits142: GlaxoSmithKline Plc - Segment focus
Exhibits143: Hanmi Pharm Co. Ltd. - Overview
Exhibits144: Hanmi Pharm Co. Ltd. - Product / Service
Exhibits145: Hanmi Pharm Co. Ltd. - Key offerings
Exhibits146: Ipsen Pharma - Overview
Exhibits147: Ipsen Pharma - Business segments
Exhibits148: Ipsen Pharma - Key offerings
Exhibits149: Ipsen Pharma - Segment focus
Exhibits150: Merck and Co. Inc. - Overview
Exhibits151: Merck and Co. Inc. - Business segments
Exhibits152: Merck and Co. Inc. - Key news
Exhibits153: Merck and Co. Inc. - Key offerings
Exhibits154: Merck and Co. Inc. - Segment focus
Exhibits155: Novartis AG - Overview
Exhibits156: Novartis AG - Business segments
Exhibits157: Novartis AG - Key offerings
Exhibits158: Novartis AG - Segment focus
Exhibits159: Novo Nordisk AS - Overview
Exhibits160: Novo Nordisk AS - Business segments
Exhibits161: Novo Nordisk AS - Key offerings
Exhibits162: Novo Nordisk AS - Segment focus
Exhibits163: Pfizer Inc. - Overview
Exhibits164: Pfizer Inc. - Product / Service
Exhibits165: Pfizer Inc. - Key news
Exhibits166: Pfizer Inc. - Key offerings
Exhibits167: Sanofi SA - Overview
Exhibits168: Sanofi SA - Business segments
Exhibits169: Sanofi SA - Key news
Exhibits170: Sanofi SA - Key offerings
Exhibits171: Sanofi SA - Segment focus
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits175: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Validation techniques employed for market sizing
Exhibits181: Information sources
Exhibits182: List of abbreviations
Companies Mentioned
Abbott Laboratories
Acerus Pharmaceuticals Corp.
Ascendis Pharma AS
Bayer AG
Beta Cell NV
Biocon Ltd.
Eli Lilly and Co.
Endo International Plc
F. Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Hanmi Pharm Co. Ltd.
Ipsen Pharma
Merck and Co. Inc.
Novartis AG
Novo Nordisk AS
Oramed Pharmaceuticals Inc.
Pfizer Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.
VeroScience LLC
Methodology
Our market research methodology is designed to provide the clients with comprehensive and accurate information
on various
industries and markets. It includes data collection, primary interviews, macro-economic factor analysis,
country-level data
analysis etc.
The data is gathered from a wide range of sources, including industry reports, government statistics, and
company financials.
This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary
interviews are conducted
with industry experts and key stakeholders to gather their insights and perspectives on the market. This
information is then
combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis
is also carried
out to understand the impact of external factors on the market. Finally, country-level data analysis is
performed to
understand the market dynamics in specific regions and countries.
Reportlinker's market research methodology is designed to provide clients with a clear understanding of the
market, its trends,
and its future potential.
Related Topics
Related Reports
+ See all
Related Reports
More Reports
